July 14, 2020

Tremfya Receives New Psoriatic Arthritis Indication

Read More
July 14, 2020

Multiple Companies Recall Metformin ER Products Due to NDMA

Read More
July 9, 2020

Botox Approved for Expanded Spasticity Indication

Read More
July 9, 2020

Dysport Receives Expanded Indication for Spasticity

Read More
July 9, 2020

Upneeq Becomes First FDA-Approved Medication for Ptosis

Read More
July 9, 2020

Tralement Approved as Source of Trace Elements for Certain Patients

Read More
July 9, 2020

Humira Biosimilar Approved, Expected to Launch in 2023

Read More
July 7, 2020

Mylan Recalls One Lot of Daptomycin for Injection

Read More
July 7, 2020

Inqovi Approved as First Oral Treatment for Certain Blood Cancers

Read More
July 6, 2020

Qwo Approved for Moderate to Severe Cellulite

Read More
July 2, 2020

Rukobia Approved to Treat Multidrug-Resistant HIV Infection

Read More
July 1, 2020

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More